(Total Views: 311)
Posted On: 12/10/2017 10:17:25 AM
Post# of 99130
$RVXCF Lots more to follow, so far we've seen.........
-Calgary based Biotech Resverlogix (Rez-Vuhr-Lodge-Icks) started trading last week at $1.53 CDN and closed at $2.20 on Friday for a gain of 67 cents or 44%.
-The company announced approval of an $87 million (Canadian funds) investment by Chinese Pharmaceutical company Shenzhen Hepalink, the world's leading producer of Herparin Sodium, a blood thinner.
-Analyst David Kideckel of Beacon Securities recently published a report referring to Resverlogix as one of Canada's most undervalued and impressive Biotechnology companies, he rated the stock a buy with a 12 month price target of $8.55.
-The company currently has a drug, Apabetalone (Ah-Pah-Bet-Alone) in a Phase III clinical trial for the treatment of Cardio Vascular Disease
-Resverlogix trades on the TSX under the symbol RVX in the U.S with the symbol RVXCF
Cheers
-Calgary based Biotech Resverlogix (Rez-Vuhr-Lodge-Icks) started trading last week at $1.53 CDN and closed at $2.20 on Friday for a gain of 67 cents or 44%.
-The company announced approval of an $87 million (Canadian funds) investment by Chinese Pharmaceutical company Shenzhen Hepalink, the world's leading producer of Herparin Sodium, a blood thinner.
-Analyst David Kideckel of Beacon Securities recently published a report referring to Resverlogix as one of Canada's most undervalued and impressive Biotechnology companies, he rated the stock a buy with a 12 month price target of $8.55.
-The company currently has a drug, Apabetalone (Ah-Pah-Bet-Alone) in a Phase III clinical trial for the treatment of Cardio Vascular Disease
-Resverlogix trades on the TSX under the symbol RVX in the U.S with the symbol RVXCF
Cheers
(1)
(0)
Check out my blog if you like: Avoid The Bag
